Risk Management is everywhere, and is not some lofty strategic element that is limited to top floor suits making enterprise-wide decisions. Risk is just another tool in the quiver of the compliance process; it is a method for streamlining your business, like any other compliance process.
Risk Management is everywhere, and is not some lofty strategic element that is limited to top floor suits making enterprise-wide decisions. Risk is just another tool in the quiver of the compliance process; it is a method for streamlining your business, like any other compliance process.
Risk Management is becoming an integral part of the compliance process. Like anything else, Risk Management is simply a process. It’s a means of looking at potential hazards, assigning a weight to those hazards, and taking steps to control those hazards. There are many ways to look at Risk, and each industry has developed different risk based tools to suit their specific business needs. Get a glimpse at how compliance industries are utilizing risk as a core benchmarking metric for decision-making in the enterprise. Download White Paper Now.
Web: www.etq.com
Contact: info@etq.com
Profile
EtQ is the leading Quality, EHS, and Operational Risk and Compliance management software provider for identifying, mitigating and preventing high-risk events through integration, automation and collaboration. EtQ is headquartered in Farmingdale, NY, with main offices located in EMEA, the UK, and Arizona.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.